Resumen de Investigación
Analyzed using Evidence Intelligence™

Ketone Beverage Improves Apolipoproteins in Prediabetes

Última actualización 4 de septiembre de 2026

Key finding

Ingestion of the KEβHB beverage led to a significantly higher AUC for Apo C-II (p=0.023).

This study evaluated the effects of a ketone monoester beverage on apolipoproteins in adults with prediabetes, finding a significant increase in Apolipoprotein C-II levels.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the effects of a ketone monoester beverage on apolipoproteins in adults with prediabetes, finding a significant increase in Apolipoprotein C-II levels.

Clinical relevance

Understanding how dietary supplements like ketone monoesters affect apolipoproteins is crucial for managing prediabetes. Elevated Apolipoprotein C-II may have implications for lipid metabolism and cardiovascular health, making this research relevant for dietary interventions in at-risk populations.

Keep in mind

The study's sample size may limit the generalizability of the findings. Results may not apply to populations outside of prediabetic adults. The long-term effects of KEβHB on apolipoproteins remain unclear.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Yutong L, Wandia K, Sakina HB, Maxim SP. Effects of a Ketone Monoester Beverage on Apolipoproteins in Adults with Prediabetes: A Randomized Placebo-Controlled Trial. Frontiers in Nutrition. 2026;12:1726174. doi:10.3389/fnut.2025.1726174

Efectos Principales

Ingestion of the KEβHB beverage led to a significantly higher AUC for Apolipoprotein C-II (p=0.023).

No statistically significant differences were found for Apolipoprotein A-I (p=0.410).

No statistically significant differences were found for Apolipoprotein B (p=0.258).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Exogenous ketone monoester (KE), Nutrient-depleted placebo beverage and Apolipoprotein B change, Apolipoprotein B-48, Apolipoprotein E, and 6 more.

Primary intervention

Exogenous ketone monoester (KE)

Primary outcomes

  • Apolipoprotein B change
  • Apolipoprotein B-48
  • Apolipoprotein E

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

11
Evidence pairs
11
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 54

0

Related topics

11

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 11 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

Apolipoprotein B change

Exogenous ketone monoester (KE) → Apolipoprotein B change

Exogenous ketone monoester (KE) → Apolipoprotein B change

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein B-48

Exogenous ketone monoester (KE) → Apolipoprotein B-48

Exogenous ketone monoester (KE) → Apolipoprotein B-48

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein E

Exogenous ketone monoester (KE) → Apolipoprotein E

Exogenous ketone monoester (KE) → Apolipoprotein E

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Appetite Control

Exogenous ketone monoester (KE) → Appetite Control

Exogenous ketone monoester (KE) → Appetite Control

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

lipoprotein(a)

Exogenous ketone monoester (KE) → lipoprotein(a)

Exogenous ketone monoester (KE) → lipoprotein(a)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein A-I

Nutrient-depleted placebo beverage → Apolipoprotein A-I

Nutrient-depleted placebo beverage → Apolipoprotein A-I

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein B

Nutrient-depleted placebo beverage → Apolipoprotein B

Nutrient-depleted placebo beverage → Apolipoprotein B

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein B-48

Nutrient-depleted placebo beverage → Apolipoprotein B-48

Nutrient-depleted placebo beverage → Apolipoprotein B-48

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein C-II

Nutrient-depleted placebo beverage → Apolipoprotein C-II

Nutrient-depleted placebo beverage → Apolipoprotein C-II

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein C-III

Nutrient-depleted placebo beverage → Apolipoprotein C-III

Nutrient-depleted placebo beverage → Apolipoprotein C-III

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Apolipoprotein E

Nutrient-depleted placebo beverage → Apolipoprotein E

Nutrient-depleted placebo beverage → Apolipoprotein E

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • KEβHB significantly increased Apolipoprotein C-II levels by 21.8 mg/dL·min (p=0.023).
  • No significant changes were observed in Apolipoprotein A-I, B, or B-48.
  • Placebo did not affect Apolipoprotein C-II levels (p=0.798).
who this applies

A quién se aplica

  • Adults aged 18-65 with prediabetes.
  • Individuals seeking dietary interventions to manage prediabetes.
keep in mind

Tener en Cuenta

  • The study did not assess long-term health outcomes related to increased Apolipoprotein C-II.
  • Findings may not be applicable to individuals with diabetes or other metabolic disorders.
  • The effects of KEβHB on other health markers were not evaluated.
between the lines

Entre Líneas

  • The study's sample size may limit the generalizability of the findings.
  • Results may not apply to populations outside of prediabetic adults.
  • The long-term effects of KEβHB on apolipoproteins remain unclear.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Exogenous ketone monoester (KE) and Apolipoprotein B-48, Exogenous ketone monoester (KE) and Apolipoprotein B change.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Exogenous ketone monoester (KE) improve appetite control?

Emerging Evidence

Exogenous ketone monoester (KE) appears to improve appetite control.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Appetite Control

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Exogenous ketone monoester (KE) improve apolipoprotein b change?

Emerging Evidence

Current evidence does not show a clear benefit of Exogenous ketone monoester (KE) for apolipoprotein b change.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Apolipoprotein B change

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Exogenous ketone monoester (KE) improve apolipoprotein b-48?

Emerging Evidence

Current evidence does not show a clear benefit of Exogenous ketone monoester (KE) for apolipoprotein b-48.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Apolipoprotein B-48

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Exogenous ketone monoester (KE) improve apolipoprotein e?

Emerging Evidence

Current evidence does not show a clear benefit of Exogenous ketone monoester (KE) for apolipoprotein e.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Apolipoprotein E

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.